Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy

NCT03578081 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

690

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasm

Interventions

DRUG: Palonosetron Hydrochloride
DRUG: Ondansetron Hydrochloride
DRUG: Dexamethasone
DRUG: Fosaprepitant Dimeglumine
DRUG: Olanzapine
OTHER: Placebo

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]